Tempus, which uses AI to process medical data, raised $410.7M after pricing its IPO at $37 a share, the top of a marketed range, giving it a $6.1B market value (Amy Or/Bloomberg)

Amy Or / Bloomberg:
Tempus, which uses AI to process medical data, raised $410.7M after pricing its IPO at $37 a share, the top of a marketed range, giving it a $6.1B market value  —  (Updates with statement in second paragraph.)